BOXER CAPITAL, LLC
Regulatory profile
From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.
Portfolio style
Measured from the filed 13F common-share book for Sep 30, 2024, never from the firm's own description.
Closest benchmark: the Russell 2000 as of 2024-09-30, active share 98.0%; sector active share 88.1% against the combined 13F book's sector weights.
Over time 19 measured quarters
How the bands are measured
Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+.
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
65 tracked positions · as of Sep 30, 2024 · Δ vs Jun 30, 2024Portfolio Trend
Sector Breakdown
As of Sep 30, 2024| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $1,433,783,332 |
| Unclassified | 0.0% | $0 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CGEM | Cullinan Therapeutics, Inc. | +250,000 | 907,895 | $15,198,162 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| FATE | Fate Therapeutics Inc | −3,255,000 | 4,960,910 | $17,363,185 | |
| — | −2,475,000 | 2,000,000 | $0 | ||
| NKTX | Nkarta, Inc. | −1,577,744 | 4,029,606 | $18,213,819 | |
| IPSC | Century Therapeutics, Inc. | −1,001,603 | 3,900,000 | $6,669,000 | |
| PRLD | Prelude Therapeutics Inc | −860,100 | 1,708,187 | $3,535,947 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| TIL | Instil Bio, Inc. | 355,500 | $23,932,260 | |
| KYMR | Kymera Therapeutics, Inc. | 450,000 | $21,298,500 | |
| NRIX | Nurix Therapeutics, Inc. | 563,067 | $12,652,115 | |
| QURE | uniQure N.V. | 2,225,000 | $10,969,250 | |
| — | 179,000 | $10,514,460 | ||
| SRRK | Scholar Rock Holding Corp | 750,000 | $6,007,500 | |
| SMMT | Summit Therapeutics Inc. | 250,000 | $5,475,000 | |
| BCAX | Bicara Therapeutics Inc. | 135,000 | $3,438,450 | |
| ZURA | Zura Bio Ltd | 300,000 | $1,218,000 | |
| — | 752,000 | $0 | ||
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Held | 4,279,464 | $194,073,692 | 13.54% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
Held | 6,448,359 | $151,600,920 | 10.57% | |
| ONC |
BeOne Medicines Ltd.
Healthcare
|
Held | 500,000 | $112,255,000 | 7.83% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Held | 2,100,000 | $110,880,000 | 7.73% | |
| SRPT |
Sarepta Therapeutics, Inc.
Healthcare
|
Held | 650,000 | $81,178,500 | 5.66% | |
| IDYA |
IDEAYA Biosciences, Inc.
Healthcare
|
Held | 2,202,812 | $69,785,084 | 4.87% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
Held | 8,198,642 | $63,129,543 | 4.40% | |
| ARGX |
Argenx SE
Healthcare
|
Held | 100,000 | $54,208,000 | 3.78% | |
| ANAB |
Anaptysbio, Inc
Healthcare
|
Held | 1,300,000 | $43,549,935 | 3.04% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
Held | 400,000 | $35,948,000 | 2.51% | |
| LEGN |
Legend Biotech Corp
Healthcare
|
Held | 600,000 | $29,238,000 | 2.04% | |
| GERN |
Geron Corp
Healthcare
|
Held | 6,000,000 | $27,240,000 | 1.90% | |
| RCKT |
Rocket Pharmaceuticals, Inc.
Healthcare
|
Held | 1,466,051 | $27,077,961 | 1.89% | |
| RCUS |
Arcus Biosciences, Inc.
Healthcare
|
Held | 1,602,200 | $24,497,638 | 1.71% | |
| TIL |
Instil Bio, Inc.
Healthcare
|
NEW | 355,500 | $23,932,260 | 1.67% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Held | 600,000 | $23,622,000 | 1.65% | |
| IMVT |
Immunovant, Inc.
Healthcare
|
Held | 825,000 | $23,520,750 | 1.64% | |
| KYMR |
Kymera Therapeutics, Inc.
Healthcare
|
NEW | 450,000 | $21,298,500 | 1.49% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
Held | 696,480 | $20,483,476 | 1.43% | |
| KURA |
Kura Oncology, Inc.
Healthcare
|
Held | 1,000,000 | $19,540,000 | 1.36% | |
| NKTX |
Nkarta, Inc.
Healthcare
|
Reduced | 4,029,606 | $18,213,819 | 1.27% | |
| ORIC |
Oric Pharmaceuticals, Inc.
Healthcare
|
Held | 1,732,571 | $17,758,852 | 1.24% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
Held | 400,000 | $17,556,000 | 1.22% | |
| FATE |
Fate Therapeutics Inc
Healthcare
|
Reduced | 4,960,910 | $17,363,185 | 1.21% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
Held | 671,358 | $17,146,483 | 1.20% | |
| REPL |
Replimune Group, Inc.
Healthcare
|
Held | 1,536,341 | $16,838,297 | 1.17% | |
| CGEM |
Cullinan Therapeutics, Inc.
Healthcare
|
Added | 907,895 | $15,198,162 | 1.06% | |
| ARVN |
Arvinas, Inc.
Healthcare
|
Held | 608,614 | $14,990,162 | 1.05% | |
| CLYM |
Climb Bio, Inc.
Healthcare
|
Held | 2,603,190 | $13,250,237 | 0.92% | |
| RLAY |
Relay Therapeutics, Inc.
Healthcare
|
Held | 1,819,132 | $12,879,454 | 0.90% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
NEW | 563,067 | $12,652,115 | 0.88% | |
| PRTA |
Prothena Corp Public Ltd Co
Healthcare
|
Held | 690,000 | $11,543,700 | 0.81% | |
| QURE |
uniQure N.V.
Healthcare
|
NEW | 2,225,000 | $10,969,250 | 0.77% | |
|
|
NEW | 179,000 | $10,514,460 | 0.73% | ||
| OLMA |
Olema Pharmaceuticals, Inc.
Healthcare
|
Held | 650,000 | $7,761,000 | 0.54% | |
| IOVA |
Iovance Biotherapeutics, Inc.
Healthcare
|
Held | 750,000 | $7,042,500 | 0.49% | |
| IPSC |
Century Therapeutics, Inc.
Healthcare
|
Reduced | 3,900,000 | $6,669,000 | 0.47% | |
| JSPR |
Jasper Therapeutics, Inc.
Healthcare
|
Held | 350,000 | $6,583,500 | 0.46% | |
| SANA |
Sana Biotechnology, Inc.
Healthcare
|
Held | 1,545,000 | $6,427,200 | 0.45% | |
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
NEW | 750,000 | $6,007,500 | 0.42% | |
| SMMT |
Summit Therapeutics Inc.
Healthcare
|
NEW | 250,000 | $5,475,000 | 0.38% | |
| ENGN |
enGene Therapeutics Inc.
Healthcare
|
Held | 727,900 | $4,804,140 | 0.34% | |
| PRLD |
Prelude Therapeutics Inc
Healthcare
|
Reduced | 1,708,187 | $3,535,947 | 0.25% | |
| BCAX |
Bicara Therapeutics Inc.
Healthcare
|
NEW | 135,000 | $3,438,450 | 0.24% | |
| BOLD |
Boundless Bio, Inc.
Healthcare
|
Held | 711,329 | $2,468,311 | 0.17% | |
| BDTX |
Black Diamond Therapeutics, Inc.
Healthcare
|
Held | 506,000 | $2,201,100 | 0.15% | |
| ZNTL |
Zentalis Pharmaceuticals, Inc.
Healthcare
|
Held | 450,000 | $1,656,000 | 0.12% | |
| TARA |
Protara Therapeutics, Inc.
Healthcare
|
Held | 811,627 | $1,485,277 | 0.10% | |
| OBIO |
Orchestra BioMed Holdings, Inc.
Healthcare
|
Held | 238,193 | $1,224,312 | 0.09% | |
| ZURA |
Zura Bio Ltd
Healthcare
|
NEW | 300,000 | $1,218,000 | 0.08% |
Showing the top 50 of 65 positions. Create a free account to see every position, past quarters, search, filters and CSV export.
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.